Compare
TransMedics Group, Inc. vs InMode Ltd. vs Axogen, Inc. vs Integer Holdings Corp
| Latest fiscal year | TransMedics Group, Inc. TMDX | InMode Ltd. INMD | Axogen, Inc. AXGN | Integer Holdings Corp ITGR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $605.49M | $370.50M | $225.21M | $1.85B |
| Revenue growth (YoY) | +37.1% | -6.2% | +20.2% | +8.0% |
| Gross margin | 59.9% | 78.5% | 74.3% | 27.0% |
| Operating margin | 17.9% | 23.0% | -3.5% | 11.9% |
| Net margin | 31.4% | 25.3% | -7.0% | 5.5% |
| Net income | $190.29M | $93.83M | -$15.70M | $102.81M |
| EPS (Diluted) | $4.87 | $1.43 | -$0.34 | $2.89 |
| Operating cash flow | $192.84M | $85.26M | $812.0K | $196.15M |
| Free cash flow | $133.59M | $84.28M | -$2.93M | $105.12M |
| Cash & equivalents | n/a | $302.54M | $35.55M | $17.16M |
| Total assets | $1.07B | $766.43M | $221.69M | $3.41B |
| Total liabilities | $595.27M | $83.23M | $92.84M | $1.66B |
| Shareholders' equity | $473.10M | $683.20M | $128.85M | $1.75B |
| Return on year-end equity | 40.2% | 13.7% | -12.2% | 5.9% |
| Shares outstanding | 34.27M | 63.36M | 47.20M | 34.35M |
Revenue, most recent five fiscal years
| Fiscal year | TransMedics Group, Inc. | InMode Ltd. | Axogen, Inc. | Integer Holdings Corp |
|---|---|---|---|---|
| Latest | $605.49M Ended 2025-12-31 | $370.50M Ended 2025-12-31 | $225.21M Ended 2025-12-31 | $1.85B Ended 2025-12-31 |
| 1 year earlier | $441.54M Ended 2024-12-31 | $394.82M Ended 2024-12-31 | $187.34M Ended 2024-12-31 | $1.72B Ended 2024-12-31 |
| 2 years earlier | $241.62M Ended 2023-12-31 | $492.05M Ended 2023-12-31 | $159.01M Ended 2023-12-31 | $1.56B Ended 2023-12-31 |
| 3 years earlier | $93.46M Ended 2022-12-31 | $454.27M Ended 2022-12-31 | $138.58M Ended 2022-12-31 | $1.33B Ended 2022-12-31 |
| 4 years earlier | $30.26M Ended 2021-12-31 | $357.56M Ended 2021-12-31 | $127.36M Ended 2021-12-31 | $1.22B Ended 2021-12-31 |